Bicarbona Te-Based Dialysis Solution Preserves Granulocyte Functions *

Objective Intraperitoneal phagocytes play an important role in local defense in preventing continuous ambulatory peritoneal dialysis (CAPD) peritonitis. This study therefore investigates the effect of the conventional lactate-based dialysis solution-pH 5.2 (LBDS-pH 5.2) and a bicarbonate-based dialysis solution (BBDS) on various cell functions. Design We studied C5a-induced actin polymerization (AP) as a measure of the cytoskeletal alteration, phagocytosis of zymosan particles, and chemotaxis in neutrophils incubated in either LBDS-pH 5.2, LBDS-pH 7.4, or BBDS-pH 7.4, comparing the data with cells treated with phosphate-buffered saline-pH 7.4 (PBS-pH 7.4) as a control. Subjects Polymorphonuclear neutrophils (PMNs) were isolated from the blood of healthy donors and incubated with dialysis solution prior to the experiment. Results C5a-induced AP was dramatically inhibited in PMNs incubated in LBDS-pH 5.2, paralleled by a complete inhibition of phagocytosis and C5a-induced chemotaxis. In comparison, BBDS improved AP to values above the control and also nearly normalized phagocytosis. Chemotaxis markedly improved in cells treated with the low glucose-containing BBDS (Bic 20), but was still inhibited in PMNs incubated in the BBDS containing high glucose concentrations (Bic 30). Conclusion In comparison with conventional lactate-based dialysis solution-pH 5.2, bicarbonate-based dialysis solution at low osmolality better preserves neutrophil functions that involve the cytoskeleton.

[1]  J. Norgauer,et al.  Persistent inhibition of neutrophil function by glucose based dialysis solutions. , 1994, ASAIO journal.

[2]  A. Donker,et al.  In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD. , 1993, Clinical nephrology.

[3]  T. Liberek,et al.  Impact of Peritoneal Dialysis Solutions on Peritoneal Immune Defense , 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[4]  G. La Greca,et al.  Continuous Ambulatory Peritoneal Dialysis with Bicarbonate Buffer-A Pilot Study , 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[5]  J. Norgauer,et al.  Inhibition of C5a-induced actin polymerization, chemotaxis, and phagocytosis of human polymorphonuclear neutrophils incubated in a glucose-based dialysis solution. , 1993, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[6]  T. Ing,et al.  Neutrophilic Intracellular Acidosis Induced by Conventional, Lactate-Containing Peritoneal Dialysis Solutions , 1992, The International journal of artificial organs.

[7]  J. Norgauer,et al.  C5a reduces formyl peptide-induced actin polymerization and phosphatidylinositol(3,4,5)trisphosphate formation, but not phosphatidylinositol (4,5) bisphosphate hydrolysis and superoxide production, in human neutrophils. , 1992, Journal of immunology.

[8]  J. Chemnitz,et al.  Bicarbonate versus Lactate-Based Capd Fluids: A Biocompatibility Study in Rabbits , 1992, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[9]  Ing Ts,et al.  Lactate-containing versus bicarbonate-containing peritoneal dialysis solutions. , 1992 .

[10]  T. Ing,et al.  Peritoneal Dialysis using Bicarbonate-Containing Solution Sterilized by Ultrafiltration , 1991, The International journal of artificial organs.

[11]  H. Yatzidis A New Stable Bicarbonate Dialysis Solution for Peritoneal Dialysis: Preliminary Report , 1991, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[12]  M. A. Rahman,et al.  Effects of bicarbonate-containing versus lactate-containing peritoneal dialysis solutions on superoxide production by human neutrophils. , 2008, Artificial organs.

[13]  A. Morgan,et al.  Effect of dialysate fluids on phagocytosis and killing by normal neutrophils , 1987, Journal of clinical microbiology.

[14]  D. Oreopoulos Prevention of Peritonitis in Patients Undergoing CAPD , 1986 .

[15]  D. Lloyd,et al.  Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function. , 1986, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  B. Gallimore,et al.  Cytotoxicity of commercial peritoneal dialysis solutions towards peritoneal cells of chronically uremic mice. , 1986, Nephron.

[17]  L. Sklar,et al.  Relationship of actin polymerization and depolymerization to light scattering in human neutrophils: dependence on receptor occupancy and intracellular Ca++ , 1985, The Journal of cell biology.

[18]  C. Ronco,et al.  Bicarbonate buffer for CAPD solution. , 1985, Transactions - American Society for Artificial Internal Organs.

[19]  T. Howard,et al.  Chemotactic peptide modulation of actin assembly and locomotion in neutrophils , 1984, The Journal of cell biology.

[20]  C. Galanos,et al.  Granulocyte activation by endotoxin. I. Correlation between adherence and other granulocyte functions, and role of endotoxin structure on biologic activity. , 1983, Journal of immunology.

[21]  S. Vas,et al.  Microbiologic aspects of chronic ambulatory peritoneal dialysis. , 1983, Kidney international.

[22]  A. Duwe,et al.  Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro , 1981, Infection and immunity.

[23]  C. Barton,et al.  Bicarbonate-buffered peritoneal dialysis. An effective adjunct in the treatment of lactic acidosis. , 1979, The American journal of medicine.

[24]  A. Fitz Peritoneal Dialysis in Clinical Medicine. , 1965 .